Literature DB >> 8096541

Vulnerability of oligodendroglia to glutamate: pharmacology, mechanisms, and prevention.

A Oka1, M J Belliveau, P A Rosenberg, J J Volpe.   

Abstract

Periventricular white matter injury, the principal variety of brain injury of the human premature infant, involves differentiating oligodendroglia. Nothing is known of the biochemical mechanism of oligodendroglial death in this disorder. Because an early event in periventricular white matter injury is ischemia-induced axonal disruption and because such axonal destruction could lead to a marked increase in local concentrations of glutamate, we evaluated the vulnerability of differentiating oligodendroglia to glutamate in a culture model. Oligodendroglia were isolated from mixed-glial primary cultures by a selective detachment technique and grown in a primary culture under conditions that lead to differentiation. These oligodendroglia were found to be highly vulnerable to glutamate-induced cell death. The EC50 for glutamate for a 24 hr exposure was approximately 200 microM, comparable to the value reported for neurons in conventional cerebral cortical cultures. Astrocytes, in contrast, were shown to be resistant to as much as 5 mM glutamate. Study of glutamate receptor antagonists and glutamate transport substrates showed that the glutamate-induced oligodendroglial death was not related to a receptor mechanism, as operates in neurons, but rather was secondary to glutamate uptake by the oligodendroglia. Glutamate transport by high-affinity, sodium-dependent and by sodium-independent systems was shown. The central importance of glutamate uptake for the toxic effect of glutamate was shown by total prevention of the oligodendroglial toxicity by the simultaneous inhibition of glutamate uptake by the specific inhibitor D,L-threo-beta-hydroxyaspartate. Subsequent observations showed that the toxicity of glutamate was mediated by free radical attack, the consequence of glutathione depletion, apparently caused by the action of a glutamate-cystine exchange mechanism that results in cystine and thereby glutathione depletion. Thus, addition of cystine or cysteine totally prevented the glutamate toxicity to oligodendroglia. Second, glutamate exposure led to cystine efflux. Third, glutathione levels decreased markedly in cells exposed to glutamate, and this marked decrease preceded the loss of cell viability. Fourth, glutamate toxicity could be prevented totally by exposure to different free radical scavengers, vitamin E and idebenone. The data thus show that glutamate is highly toxic to oligodendroglia. Moreover, the findings raise the possibilities that such glutamate toxicity is operative in the oligodendroglial cell death associated with ischemic processes that disrupt axons, such as periventricular white matter injury of the premature infant, and that novel therapies directed against glutamate transport, glutathione depletion, and free radical attack might be beneficial in prevention of that injury.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8096541      PMCID: PMC6576718     

Source DB:  PubMed          Journal:  J Neurosci        ISSN: 0270-6474            Impact factor:   6.167


  121 in total

1.  NMDA and glutamate evoke excitotoxicity at distinct cellular locations in rat cortical neurons in vitro.

Authors:  J D Sinor; S Du; S Venneti; R C Blitzblau; D N Leszkiewicz; P A Rosenberg; E Aizenman
Journal:  J Neurosci       Date:  2000-12-01       Impact factor: 6.167

Review 2.  The cystine/glutamate antiporter system x(c)(-) in health and disease: from molecular mechanisms to novel therapeutic opportunities.

Authors:  Jan Lewerenz; Sandra J Hewett; Ying Huang; Maria Lambros; Peter W Gout; Peter W Kalivas; Ann Massie; Ilse Smolders; Axel Methner; Mathias Pergande; Sylvia B Smith; Vadivel Ganapathy; Pamela Maher
Journal:  Antioxid Redox Signal       Date:  2012-08-03       Impact factor: 8.401

3.  System x(c)(-) regulates microglia and macrophage glutamate excitotoxicity in vivo.

Authors:  Kristina A Kigerl; Daniel P Ankeny; Sanjay K Garg; Ping Wei; Zhen Guan; Wenmin Lai; Dana M McTigue; Ruma Banerjee; Phillip G Popovich
Journal:  Exp Neurol       Date:  2011-11-04       Impact factor: 5.330

Review 4.  Unique biology of gliomas: challenges and opportunities.

Authors:  Stacey Watkins; Harald Sontheimer
Journal:  Trends Neurosci       Date:  2012-06-08       Impact factor: 13.837

Review 5.  Glutamate and the biology of gliomas.

Authors:  John de Groot; Harald Sontheimer
Journal:  Glia       Date:  2010-12-29       Impact factor: 7.452

Review 6.  Pathophysiology of glia in perinatal white matter injury.

Authors:  Stephen A Back; Paul A Rosenberg
Journal:  Glia       Date:  2014-03-31       Impact factor: 7.452

7.  Vitamin K prevents oxidative cell death by inhibiting activation of 12-lipoxygenase in developing oligodendrocytes.

Authors:  Jianrong Li; Hong Wang; Paul A Rosenberg
Journal:  J Neurosci Res       Date:  2009-07       Impact factor: 4.164

8.  Inhibition of cystine uptake disrupts the growth of primary brain tumors.

Authors:  Wook Joon Chung; Susan A Lyons; Gina M Nelson; Hashir Hamza; Candece L Gladson; G Yancey Gillespie; Harald Sontheimer
Journal:  J Neurosci       Date:  2005-08-03       Impact factor: 6.167

Review 9.  Systemic prenatal insults disrupt telencephalon development: implications for potential interventions.

Authors:  Shenandoah Robinson
Journal:  Epilepsy Behav       Date:  2005-08-02       Impact factor: 2.937

10.  Protective effects of resveratrol on glutamate-induced damages in murine brain cultures.

Authors:  Rudolf Moldzio; Khaled Radad; Christopher Krewenka; Barbara Kranner; Johanna Catharina Duvigneau; Wolf-Dieter Rausch
Journal:  J Neural Transm (Vienna)       Date:  2013-03-05       Impact factor: 3.575

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.